Sign up today and save up to 83% on a Hartford Courant digital subscription
News
News

Avandia

A bottle and pills of the diabetes drug, Avandia. The U.S. Food and Drug Administration panel voted to recommend that GlaxoSmithKline PLC's (GSK) diabetes drug, Avandia, remain on the market despite concerns that the product could raise the risk of heart attacks. (Photo by illustration Joe Raedle/Getty Images)
Loading
70°